Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOndo Insurtech Regulatory News (ONDO)

Share Price Information for Ondo Insurtech (ONDO)

Share Price is delayed by 15 minutes
Get Live Data
6.85    -0.10 (-1.47%)
Bid:
6.70
Ask:
7.00
Spread: 0.30 (4.478%)
Market Cap: £10.04m
ONDO Live PriceLast checked at - London Stock Exchange

Intraday Ondo Insurtech Share Chart

Director/PDMR Share Dealing

11 Mar 2025 16:56

RNS Number : 2525A
Ondo InsurTech PLC
11 March 2025
 

11 March 2025

Ondo Insurtech Plc

("Ondo" or the "Company")

 

Director/PDMR Share dealing

 

Ondo Insurtech (LSE: ONDO), a leading company in claims prevention technology for home insurers, announces that Charlene Hill, spouse of Chief Executive, Craig Foster, exercised warrants over 125,000 ordinary shares of 5 pence each in the capital of the Company ("Ordinary Shares") at an exercise price of 25 pence per warrant on 7 March 2025 ("New Ordinary Shares"). On the same day, Charlene Hill also sold 105,000 Ordinary shares (to cover taxes and exercise costs) at a price of 35.8 pence, having previously held 250,000 Ordinary Shares. Following the warrant exercise and share sale Charlene Hill is now interested in 270,000 Ordinary Shares, which represents approximately 0.21% of the issued share capital of the Company.

 

The New Ordinary Shares have been admitted to listing on the Equity Shares (Transition) category of the Official List of the Financial Conduct Authority and to trading on the London Stock Exchange's main market for listed securities under the Company's block listing.

 

Charlene Hill's interests in the Company were acquired through her participation in the fundraising undertaken by the Company in March 2022 in conjunction with its acquisition of the entire issued share capital of LeakBot Limited by way of a reverse takeover. At that time Charlene Hill was not a person closely associated ("PCA") with Craig Foster for UK MAR purposes. Following their marriage in August 2023, Charlene Hill has been a PCA with Craig Foster and accordingly, her interests should have been incorporated with and reflected when reporting the interests of Craig Foster, but this disclosure was not made in error.

 

Craig Foster's interests in the Company as at 1 August 2023 were as set out below:

 

 

Shareholding at August 2023

% of issued share capital

Number of warrants

Number of share options

Craig Foster

1,779,567

2.23%

889,783

2,320,000

Charlene Hill

250,000

0.32%

125,000

-

Total

2,029,567

2.55%

1,014,783

2,320,000

 

Following the share sale and exercise of warrants described above, as at 11 March 2025, Craig Foster's beneficial interests in the Company are now:

 

 

Shareholding(1)

% of issued share capital

Number of warrants

Number of share options

Craig Foster

2,448,844

1.90%

-

3,920,000

 

(1) 270,000 Ordinary Shares are held by Craig Foster's wife

 

 

 

Enquiries

 

Ondo InsurTech Plc

Craig Foster, CEO

Kevin Withington, CFO

+44 (0) 800 783 9866

Dowgate Capital Ltd

(Broker & Financial Advisor)

Russell Cook

Nick Chambers

Charlie Hall

+44 (0) 20 3903 7715

 

Cassiopeia Services Ltd

(PR & Investor Relations)

Stefania Barbaglio

 +44 (0) 7949 690338

 

 

The information set out below is provided in accordance with the requirements of Article 19 of the Market Abuse Regulations.

 

1.

Details of PDMR / person closely associated with them ("PCA").

a)

Name

Charlene Hill

2

Reason for notification

a)

Position/Status

PCA - spouse of Craig Foster, Chief Executive and PDMR

b)

Initial Notification / amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer

or auction monitor

a)

Name

Ondo InsurTech Plc

b)

LEI

2138005Y5QBJQMOOI719

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial

Ordinary shares of 5 pence each

instrument, type of instrument

 

Identification code

ISIN: GB00BNVVGD77

b)

Nature of transaction

Exercise of warrants for ordinary shares

c)

Price(s) and volume(s)

Exercise of warrants over 125,000 Ordinary Shares at an exercise price of 25 pence per warrant

 

d)

Aggregated information

n/a

e)

Date of transaction

7 March 2025

f)

Place of transaction

Outside of a trading venue

 

 

1.

Details of PDMR / person closely associated with them ("PCA").

a)

Name

Charlene Hill

2

Reason for notification

a)

Position/Status

PCA - spouse of Craig Foster, Chief Executive and PDMR

b)

Initial Notification / amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer

or auction monitor

a)

Name

Ondo InsurTech Plc

b)

LEI

2138005Y5QBJQMOOI719

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial

Ordinary shares of 5 pence each

instrument, type of instrument

 

Identification code

ISIN: GB00BNVVGD77

b)

Nature of transaction

Sale of Ordinary Shares

c)

Price(s) and volume(s)

 

Price

Volumes

35.8p

105,000

 

 

d)

Aggregated information

n/a

e)

Date of transaction

7 March 2025

f)

Place of transaction

London Stock Exchange, Main Market (XLON)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHQFLFFEXLEBBX
Date   Source Headline
30th Nov 20235:30 pmRNSResult of Equity Issue
30th Nov 20235:00 pmRNSProposed placing to raise up to £1.08 million
30th Nov 20234:30 pmRNSTotal Voting Rights
20th Nov 20237:00 amRNSInterim Results
14th Nov 20237:00 amRNSNationwide Partners with Ondo for LeakBot in U.S.
13th Nov 20237:00 amRNSNotice of Results
30th Oct 20237:00 amRNSAppointment of Dowgate Capital
29th Sep 20237:00 amRNSTotal Voting Rights
25th Sep 20235:53 pmRNSResult of AGM
22nd Sep 20237:00 amRNSWarrant, Options Exercise, Total Voting Rights
1st Sep 20239:56 amRNSTotal Voting Rights
15th Aug 20237:30 amRNSDirector/PDMR Shareholding
15th Aug 20237:00 amRNSWarrant / Options / Total Voting Rights Update
8th Aug 20237:17 amRNSNew Partnership with PURE Insurance
3rd Aug 20237:00 amRNSNotification of major holdings
2nd Aug 20231:56 pmRNSNotification of Major Holdings
1st Aug 20239:28 amRNSTotal Voting Rights and Shares in issue update
31st Jul 20231:53 pmRNSAnnual Financial Report and AGM Notice
17th Jul 20237:00 amRNSWaterwise makes Ondo an Affiliate Partner
11th Jul 20237:00 amRNSLoan Note restructuring to support rapid growth
10th Jul 20237:00 amRNSNew five-year contract
5th Jul 20231:47 pmRNSBlock listing Application
30th Jun 20237:00 amRNSAccounting Reference Period
29th Jun 20237:00 amRNSNew deal signed for Australia and New Zealand
14th Jun 20237:00 amRNSNew rapid pilot programme with G4S in Denmark
7th Jun 20237:00 amRNSNew contract with premium US insurer
6th Jun 20237:00 amRNSPortsmouth Water LeakBot Pilot Results Announced
22nd May 20237:00 amRNSPortsmouth Water to share LeakBot Pilot results
15th May 20239:44 amRNSHolding(s) in Company
12th May 20239:44 amRNSPlacing, Subscription and Director/PDMR Dealing
20th Apr 20237:00 amRNSOndo and WNS sign go-to-market channel partnership
1st Feb 20237:00 amRNSDirector / PDMR Dealing
30th Jan 20237:00 amRNSLänsförsäkringar commences LeakBot rollout
16th Jan 20237:00 amRNSNew Danish Contract
21st Nov 202211:42 amEQSOndo InsurTech looking at 'absolutely huge opportunity' in the US
21st Nov 20227:00 amRNSInvestor Event
14th Nov 20221:59 pmEQSOndo InsurTech wins LeakBot contract extension with Hiscox
14th Nov 20227:00 amRNSInterim Results for six months ended 31/08/2022
9th Nov 20227:00 amRNSHiscox signs contract renewal for LeakBot in UK
8th Nov 202211:29 amRNSHolding(s) in Company
26th Sep 202210:19 amRNSAppointment of CFO to Board of Directors
26th Sep 20227:00 amRNSChange of Accounting Reference Period
5th Sep 20227:00 amRNSOndo InsurTech Appoints Kevin Withington as CFO
22nd Aug 20223:31 pmRNSResult of Annual General Meeting
18th Aug 202211:13 amRNSPortsmouth Water Sign Deal
12th Aug 20223:41 pmRNSPDMR Shareholding
10th Aug 20227:00 amRNSPDMR Shareholding
4th Aug 20227:00 amRNSOndo InsurTech receives LSE Green Economy Mark
3rd Aug 20227:00 amRNSPDMR Shareholding
1st Aug 20225:07 pmRNSDirector/PDMR Dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.